| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/05/2009 | US20090035353 Non-absorbent articles containing additives |
| 02/05/2009 | US20090035352 Drug Delivery Particle |
| 02/05/2009 | US20090035350 Polymers for implantable devices exhibiting shape-memory effects |
| 02/05/2009 | US20090035348 Dissolution of arterial plaque |
| 02/05/2009 | US20090035345 Nuclear Receptors Agonists for Treatment of Atherosclerosis and/or Related Cardiovascular Disease |
| 02/05/2009 | US20090035342 Antimicrobial Devices and Compositions |
| 02/05/2009 | US20090035340 Preservative compositions for moist wipes |
| 02/05/2009 | US20090035339 Methods of Inactivating Viruses |
| 02/05/2009 | US20090035338 Inverse emulsions comprising avermectins and cosmetic/dermatological applications thereof |
| 02/05/2009 | US20090035336 Isoflavone nanoparticles and use thereof |
| 02/05/2009 | US20090035332 Pharmaceutical formulation |
| 02/05/2009 | US20090035331 Systems and Methods for Targeted and Controlled Delivery of Agents |
| 02/05/2009 | US20090035329 Diagnostic and treatment methods for characterizing bacterial microbiota in skin conditions |
| 02/05/2009 | US20090035324 N-(2-(4-(4-fluoro(benzyl-d6)carbamoyl)-5-hydroxy-1-(methyl-d3)-6-oxo-1,6-dihydropyrimidin-2-yl)-(1,3-d6-propan)-2-yl)-5-(methyl-d3)-1,3,4-oxadiazole-2-carboxamide; use in methods of treating HIV infections |
| 02/05/2009 | US20090035315 Method of Improving Treatments in Rheumatic and Arthritic Diseases |
| 02/05/2009 | US20090035314 Method and pharmaceutical composition for preventing or treating diseases associated with inflammation |
| 02/05/2009 | US20090035313 Compounds |
| 02/05/2009 | US20090035312 Tumor angiogenesis associated genes and a method for their identification |
| 02/05/2009 | US20090035310 Cancer treatment |
| 02/05/2009 | US20090035309 Substituted Benzazoles and Methods of Their Use as Inhibitors of RAF Kinase |
| 02/05/2009 | US20090035306 Quinazolinone modulators of tgr5 |
| 02/05/2009 | US20090035302 Rage Antagonists As Agents To Reverse Amyloidosis And Diseases Associated Therewith |
| 02/05/2009 | US20090035301 Methods for diagnosing and treating bladder cancer |
| 02/05/2009 | US20090035299 Methods and compositions for treating diseases targeting MABA1 |
| 02/05/2009 | US20090035298 Methods to treat alzheimer's disease or other amyloid beta accumulation associated disorders |
| 02/05/2009 | US20090035297 Methods for treating diabetes |
| 02/05/2009 | US20090035296 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 02/05/2009 | US20090035294 Lipopolysaccharide fractions of vitreoscilla filiformis useful for stimulating the synthesis of anti-microbial peptides of the skin |
| 02/05/2009 | US20090035292 Use of phosphatases to treat neuroblastomas and medulloblastomas |
| 02/05/2009 | US20090035291 Therapeutic use of adpase enhanced apyrases |
| 02/05/2009 | US20090035287 Atrial natriuretic peptide (anp) splice variants and methods of using same |
| 02/05/2009 | US20090035282 Pluripotent embryonic-like stem cells derived from teeth and uses thereof |
| 02/05/2009 | US20090035281 Combination of interleukin-6 antagonists and antiproliferative drugs |
| 02/05/2009 | US20090035279 Genetic variants on chr 15q24 as markers for use in diagnosis, prognosis and treatment of exfoliation syndrome and glaucoma |
| 02/05/2009 | US20090035277 Hepatitis C Virus Nucleic Acid Vaccine |
| 02/05/2009 | US20090035275 Methods and formulations for protecting cells, and for treating diseases and conditions by optimizing the intracellular concentration of NAD |
| 02/05/2009 | US20090035274 Treatment and/or prevention of cancer and/or arthritis |
| 02/05/2009 | US20090035271 Tetrazolyl macrocyclic hepatitis c serine protease inhibitors |
| 02/05/2009 | US20090035268 Tetrazolyl acyclic hepatitis c serine protease inhibitors |
| 02/05/2009 | US20090035267 Acyclic, pyridazinone-derived hepatitis c serine protease inhibitors |
| 02/05/2009 | US20090035266 Immunogenic peptides and methods of use |
| 02/05/2009 | US20090035265 Compositions and Methods for Targeted Delivery of Factors |
| 02/05/2009 | US20090035256 Modified interleukin 10 polypeptide for use in treatment and prevention of neuropathic pain, neurological and inflammatory disorders |
| 02/05/2009 | US20090035251 Method of applying an injectable filler |
| 02/05/2009 | US20090035250 Compositions and methods for treating cavity conditions |
| 02/05/2009 | US20090035249 Method of inhibiting proliferation of Escherichia coli |
| 02/05/2009 | US20090035248 Fast Degrading Polymers |
| 02/05/2009 | US20090035242 Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And Linear Or Branched Silicone |
| 02/05/2009 | US20090035228 Skin and surface disinfectant compositions containing botanicals |
| 02/05/2009 | US20090035225 RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF GLAUCOMA |
| 02/05/2009 | US20090035224 Methods of Using Albuterol and Calcium Activated Potassium Channel Openers |
| 02/05/2009 | US20090035219 CB1 receptor antagonists and uses thereof |
| 02/05/2009 | US20090035215 Radiofluorination |
| 02/05/2009 | US20090032049 Ventilated Device for Delivery of Agents to and through the Human Scalp |
| 02/05/2009 | DE19963179B4 Substituierte 1- und 2-Naphthol-Mannichbasen Substituted 1- and 2-naphthol Mannich bases |
| 02/05/2009 | DE19805822B4 11-Acetyl-12,13-dioxabicyclo[8.2.1]tridecenon-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel 11-acetyl-12,13-dioxabicyclo [8.2.1] tridecenon derivatives, processes for their preparation and pharmaceutical compositions containing them |
| 02/05/2009 | DE102008033254A1 Verfahren zur Herstellung eines einphasischen pharmazeutischen Präparates zur oralen Therapie der Regulierung des Blutdruckes A method for producing a pharmaceutical preparation for the oral therapy einphasischen the regulation of blood pressure |
| 02/05/2009 | DE102007036076A1 Dipeptoid-Produgs und ihre Verwendung Dipeptoid prodrugs and their use |
| 02/05/2009 | DE102007036075A1 Prodrugs und ihre Verwendung Prodrugs and their use |
| 02/05/2009 | DE102007035741A1 Stabilisierung kosmetischer oder dermatologischer Formulierung enthaltend Mandelsäure Stabilization of cosmetic or dermatological formulation containing mandelic acid |
| 02/05/2009 | CA2853992A1 Use of genomic testing and ketogenic compounds for treatment of reduced cognitive function |
| 02/05/2009 | CA2823372A1 Pharmaceutical composition for treating wounds and related methods |
| 02/05/2009 | CA2719824A1 Methods and compositions for treating schizophrenia using antipsychotic combination therapy |
| 02/05/2009 | CA2705625A1 Improved formulations of candesartan |
| 02/05/2009 | CA2700004A1 Novel immunotherapy strategy |
| 02/05/2009 | CA2698749A1 Sublingual fentanyl spray |
| 02/05/2009 | CA2698305A1 Effervescent solid pharmaceutical composition comprising dextrose and process for its preparation |
| 02/05/2009 | CA2698170A1 Prodrugs of 2-amino-6- ( { [2- (4-chlorphenyl) -1, 3-thiaz0l-4-yl] methyl}thio) -4- [4- ( 2 -hydroxyethoxy) phenyl] pyridin-3, 5-dicarbonitrile |
| 02/05/2009 | CA2697345A1 Stereoselective process for preparing purine dioxolane nucleoside derivatives |
| 02/05/2009 | CA2697147A1 Cyclic inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1 |
| 02/05/2009 | CA2696005A1 5'-substituted adenosynes, preparation thereof and use as inhibitors of s-adenosylmethionine decarboxylase |
| 02/05/2009 | CA2695660A1 Adefovir dipivoxil crystalline monohydrate form |
| 02/05/2009 | CA2695384A1 Bi-dentate compounds as kinase inhibitors |
| 02/05/2009 | CA2695304A1 Pyrimidine and pyridine derivatives and their pharmaceutical use and compositions |
| 02/05/2009 | CA2695297A1 Substituted cc-1065 analogs and their conjugates |
| 02/05/2009 | CA2695282A1 Medicaments and methods for inhibition of non-ocular scarring |
| 02/05/2009 | CA2695259A1 Metabolites and derivatives of ambrisentan |
| 02/05/2009 | CA2695257A1 Anti-inflammatory composition |
| 02/05/2009 | CA2695214A1 Transdermal administration of (2s)-(4e)-n-methyl-5-(3-(5-is0pr0p0xypyridin)yl)-4-penten-2-amine |
| 02/05/2009 | CA2695203A1 Improved method for the synthesis of substituted formylamines and substituted amines |
| 02/05/2009 | CA2695197A1 Integrated photoactive agents and uses thereof |
| 02/05/2009 | CA2695196A1 Naphthyridine derivatives as potassium channel modulators |
| 02/05/2009 | CA2695178A1 Methods for producing aripiprazole suspension and freeze-dried formulation |
| 02/05/2009 | CA2695156A1 Vinyl-aryl derivatives for inflammation and immune-related uses |
| 02/05/2009 | CA2695148A1 Pyridine compounds for inflammation and immune-related uses |
| 02/05/2009 | CA2695143A1 Heterocycle-aryl compounds for inflammation and immune-related uses |
| 02/05/2009 | CA2695114A1 Pyrazole compounds and their use as raf inhibitors |
| 02/05/2009 | CA2695071A1 The use of benzamide derivatives for the treatment of cns disorders |
| 02/05/2009 | CA2694953A1 Compositions including androgen receptor degradation (ard) enhancers and methods of prophylactic or therapeutic treatment of skin disorders and hair loss |
| 02/05/2009 | CA2694928A1 Micro-rnas that control myosin expression and myofiber identity |
| 02/05/2009 | CA2694927A1 Pharmaceutical composition for treating wounds and related methods |
| 02/05/2009 | CA2694925A1 Use of genomic testing and ketogenic compounds for treatment of reduced cognitive function |
| 02/05/2009 | CA2694887A1 Use of kncq potassium channel openers for reducing symptoms of or treating disorders or conditions wherein the dopaminergic system is disrupted |
| 02/05/2009 | CA2694724A1 Cyclic inhibitors of carnitine palmitoyltransferase and treating cancer |
| 02/05/2009 | CA2694663A1 5-phenyl-isoxazole-3-carboxamide derivatives as trpv1 modulators |
| 02/05/2009 | CA2694639A1 Benzamidine derivatives, process for the preparation thereof and pharmaceutical composition for preventing or treating osteoporosis comprising the same |
| 02/05/2009 | CA2694638A1 Preventive or therapeutic agent for diseases caused by abnormal bone metbolism |
| 02/05/2009 | CA2694635A1 Uses of trientine and penicillamine as countermeasures to metal contamination |
| 02/05/2009 | CA2694608A1 A process for the preparation of almotriptan and a synthetic intermediate usable in said process |
| 02/05/2009 | CA2694567A1 Pharmaceutical composition containing optically active compound having thrombopoietin receptor agonist activity and intermediate thereof |